Emerging risks | Growth Opportunities | APAC Insurance

Saturday, November 14, 2026

Accident and Health, Life and Health, Non-life, Reinsurance, Takaful

Malaysian Re, China Re Life back cancer precision medicine reinsurance framework

The move will provide reinsurance and retakaful capacity for insurance and takaful products covering selected advanced cancer treatments.

By

Reih Angeles

June 19, 2026

•

2 min read

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

14 days of access to (Re)in Asia’s premium intelligence
Free daily briefing in your inbox each morning
No credit card required

Already have an account? Sign in →

(Re)in AsiaSIRC 2026 Hub

(Re)in AsiaSIRC 2026HubExplore the hub →

Read next

China's Sunshine Insurance registers 12.5% H1 premium growth on back of life business September 3 2026
Price takes a back seat as cedents seek strategic reinsurance purchases November 3 2026
AXA XL brings Augustin Gas back to Singapore to lead Asia reinsurance September 5 2026
Lloyd’s sets framework for broker-originated reinsurance structures from 2027 October 27 2026
Malaysian Life Re posts 10.8% return on equity in 2025 as AM Best affirms ratings August 28 2026
Malaysian Re's combined ratio improves to 78% as Fitch affirms ratings November 9 2026